HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Starpharma’s Antibiotic-Free BV Gel Launched In The UK

Executive Summary

Australian sexual health specialist Starpharma launches its innovative, antibiotic-free Viva Gel BV bacterial vaginosis treatment in the UK. 

You may also be interested in...



Signs Of Life In The Bacterial Vaginosis, Vulvovaginal Candidiasis Pipeline

Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.

Starpharma’s Innovative VivaGel Condom Ready For Launch in Japan

Starpharma has received approval for its innovative VivaGel condom in Japan, which will be launched in the first half of 2019 by Okamoto Industries. 

Don’t Get Caught In Long-COVID OTC Painkiller ‘Hamster Wheel,’ Warn German Neurologists

A significant proportion of COVID-19 headache sufferers go on to develop “new daily persistent headaches” syndrome. German neurologists warn that these people are at danger of medication overuse headaches, as well as kidney damage, as a result of taking OTC analgesics on a daily basis. 

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS149461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel